Streetbeat News

Products Services

PLRX

Pliant Therapeutics presented data on their bexotegrast program at the American Thoracic Society 2024 International Conference. The data showed that bexotegrast was well tolerated across multiple studies, including Phase 1 and Phase 2 trials, with most adverse events being mild to moderate.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 7:51 am

HYMTF

Hyundai Motor unveils its vision for a hydrogen society and U.S. clean logistics at ACT Expo 2024, introducing its U.S. hydrogen commercial vehicle business and announcing a new clean logistics partnership with GLOVIS America.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 7:48 am

BYDDF

TSLA

BYD Co. (OTC:BYDDF) is set to launch its budget-friendly Seagull EV in Europe, challenging local automakers with a sub-$21K price tag. The move intensifies competition in the EV market, particularly affecting Tesla (NASDAQ:TSLA) and other European manufacturers.

Portfolio Pulse from Benzinga Neuro

May 22, 2024 | 6:50 am

ETHUSD

MSFT

Ethereum co-founder Vitalik Buterin has criticized the push for superintelligent AI, particularly targeting OpenAI's $7 trillion investment plan. He advocates for decentralized AI models running on consumer hardware to mitigate risks associated with centralized power.

Portfolio Pulse from Aniket Verma

May 22, 2024 | 6:50 am

NSANY

Nissan Motor Co (OTC:NSANY) has paused its plans for two electric sedans in the U.S. while expanding its EV lineup to five vehicles, focusing on SUVs due to changing market trends. The company aims to introduce 30 new models by 2026, with 16 being electrified, to boost global sales and profitability.

Portfolio Pulse from Benzinga Neuro

May 22, 2024 | 6:35 am

ACN

Accenture announced its acquisition of Partners In Performance to enhance productivity for asset-intensive industries. The terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 6:33 am

ABUS

Arbutus Biopharma announced the presentation of data on its drug imdusiran at the EASL Congress 2024. Key findings include a significant percentage of subjects achieving HBsAg ≤ LLOQ with detectable anti-HBs after receiving 4 or 6 doses of imdusiran plus 24 weeks of IFN. The study is ongoing, with more data to be presented.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 6:29 am

AAPL

AMD

NVDA

Renowned investor Steve Eisman, known for his role in 'The Big Short,' has identified Apple Inc. (AAPL) as a major player in the AI market, suggesting it could see substantial gains from AI-driven apps. Eisman also highlighted Nvidia (NVDA) and Advanced Micro Devices (AMD) as obvious AI investment opportunities.

Portfolio Pulse from Benzinga Advisor

May 22, 2024 | 6:23 am

DBD

Diebold Nixdorf has launched Vynamic Connection Points 7, a new generation of its multivendor, self-service software. VCP 7 is designed for easy deployment and maintenance, offering out-of-the-box, end-to-end consumer journeys.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 6:22 am

F

PEP

TSLA

PepsiCo is expanding its electric vehicle fleet by adding 75 Ford E-Transit vans and 50 Tesla Semi trucks. This move aligns with PepsiCo's goal of achieving net-zero emissions by 2040. The company has also installed Tesla chargers and Megapack Battery Energy Storage Systems at its Fresno facility.

Portfolio Pulse from Anan Ashraf

May 22, 2024 | 6:14 am